DEPLOYDatabase

Robot model

Edison Histotripsy System

Robotic, image-guided focused ultrasound (histotripsy) platform that mechanically destroys and liquefies targeted tumors non-invasively without incisions.

Manufacturer
HistoSonics
Form factor
surgical
Maturity
commercial
Lifecycle
active

Overview

Robotic, image-guided focused ultrasound (histotripsy) platform that mechanically destroys and liquefies targeted tumors non-invasively without incisions. Uses a robotic arm to deliver focused ultrasound energy. First and only histotripsy platform cleared for clinical use globally.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Verified deployments
None on file
Sources on file
2 sources, view all

No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.

Key facts

FDA clearance

De Novo 2023 (liver tumors)

Type

Robotic histotripsy / focused ultrasound

Maturity

Commercial / FDA-cleared

Applications

Liver tumors (cleared), kidney (pending), pancreatic (planned)

Data & sources

Web sources

2

2 sources backing this record.View all →

Autonomy: verified vs claimed

What it actually does
Supervised (human oversight)

Pricing

No verified price is on record for Edison Histotripsy System. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Edison Histotripsy System on the deployment map

Where Edison Histotripsy System is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Edison Histotripsy System.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://histosonics.com/
  2. https://www.massdevice.com/histosonics-edison-histotripsy-fda-kidney-tumors/

Common questions

What is Edison Histotripsy System?
Robotic, image-guided focused ultrasound (histotripsy) platform that mechanically destroys and liquefies targeted tumors non-invasively without incisions. Uses a robotic arm to deliver focused ultrasound energy. First and only histotripsy platform cleared for clinical use globally.
How much does Edison Histotripsy System cost?
Edison Histotripsy System's price is not publicly disclosed. DEPLOY has no verified price on record for Edison Histotripsy System from HistoSonics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Edison Histotripsy System actually deployed in the real world?
Edison Histotripsy System is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.
Who makes Edison Histotripsy System?
Edison Histotripsy System is made by HistoSonics, based in Plymouth, MN, USA, founded in 2009.
Can you buy Edison Histotripsy System?
Edison Histotripsy System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Methodology: Unreviewed · 2 sources (no primary) · last reviewed 2026-07-23

Verification posture

Unreviewed

Low confidence

Review state

Stable

Last reviewed 2026-07-23

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

2
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Edison Histotripsy System.